Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Filings indexed 1,772 across all filing types
Latest filing 2025-02-14 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Notification of Major Holdings' and details the acquisition/disposal of shares and instruments, crossing specific percentage thresholds (5.02% total). It references specific German securities law articles (WpHG) and reports on changes in voting rights held by a major shareholder (T. Rowe Price Group, Inc.). This directly corresponds to the definition of a Major Shareholding Notification, which is classified under the code MRQ.
2025-02-14 English
Declaration of Voting Results & Voting Rights Announcements 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' by T. Rowe Price Group, Inc. in Evotec SE. It specifies the date the threshold was crossed (07 Feb 2025) and details the percentage of voting rights attached to shares and instruments. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing regulatory thresholds. The appropriate code is MRQ.
2025-02-13 English
Declaration of Voting Results & Voting Rights Announcements 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting rights Announcements' and explicitly contains a 'Notification of Major Holdings' section. It details changes in the percentage of voting rights held by T. Rowe Price Group, Inc. in Evotec SE, crossing specific thresholds (3.01% direct voting rights). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. Reviewing the definitions: - 10-K/IR: Not a full annual or interim financial report. - ER: Not an earnings release. - DVA: This is about voting rights, but specifically about *major holdings* changes, not the *results* of a shareholder vote. - MRQ (Major Shareholding Notification): This category perfectly matches the content, which reports changes in major share ownership (crossing thresholds). Therefore, the classification is MRQ.
2025-02-13 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is titled 'Voting rights Announcements' and explicitly contains a 'Notification of Major Holdings' section. It details changes in the percentage of voting rights held by T. Rowe Price Group, Inc. in Evotec SE, crossing specific thresholds (3.01% direct voting rights). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. Reviewing the definitions: - 10-K/IR: Not a full annual or interim financial report. - ER: Not an earnings release. - DVA: This is about voting rights, but specifically about *major holdings* changes, not the *results* of a shareholder vote. - MRQ (Major Shareholding Notification): This category perfectly matches the content, which reports changes in major share ownership (crossing thresholds). Therefore, the classification is MRQ.
2025-02-12 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'Voting rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' by UBS Group AG in Evotec SE. It specifies the acquisition/disposal of shares with voting rights, the date the threshold was crossed (04 Feb 2025), and the resulting total positions in terms of voting rights percentages and absolute numbers, referencing German Securities Trading Act (WpHG) sections. This content directly aligns with regulations concerning changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category.
2025-02-10 English
Evotec SE: Dr. Cord Dohrmann, Exercise against Cash Settlement (Share Performance Plan)
Director's Dealing Classification · 1% confidence The document explicitly states 'Directors’ Dealings' in the header and details a transaction ('Exercise against Cash Settlement (Share Performance Plan)') by a 'Member of the managing body' (Dr. Cord Dohrmann). This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2025-02-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.